Ozempic wegovy weight loss

Semaglutide (GLP1)

This is the most popular weight loss peptide on the market approved by the FDA in 2021. The more commonly prescribed forms are known as Ozempic or Wegovy. Semaglutide prompts the body to produce more insulin, which reduces blood sugar (glucose). GLP-1 also interacts with the parts of the brain that suppress your appetite and signal you to feel full. When used in conjunction with diet and exercise, it can cause significant weight loss — and a reduced risk of cancer, diabetes and heart disease in people who are obese or overweight. A monthly Ozempic prescription can cost $800 – 1,200 compared to roughly $138 through us, to your door from the pharmacy. Making this a much more cost effective and affordable option. This is a once per week subcutaneous injection. Which is a tiny insulin type syringe taken in the belly fat.


Tirzepatide GLP-1/GIP

Tirzepatide is newer to the market and is the active peptide found in a commonly known brand Mounjaro. It works as a dual GLP-1 agonist and GIP agonist to maximize similar benefits that are seen with GLP-1 medications such as semaglutide. Tirzepatide has been shown to work similarly to GLP-1 (semaglutide) medications but with greater efficacy. Given its weight loss properties and lack of liver toxicity, it is likely to play an indirect role in the treatment of nonalcoholic fatty liver disease. This is also a once per week subcutaneous injectable peptide. This may be a good alternative for a more aggressive weight loss approach or if semaglutide becomes less effective. A monthly Mounjaro prescription can run between 1k – $1,500 which is not covered by insurance if not prescribed for type 2 diabetes. 

Mounjaro weight loss

Article Summaries from Scientific Research

Scroll to Top